We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+11.3%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$30.9B
AUM Growth
+$2.04B
(+7.1%)
Cap. Flow
-$960M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
59.96%
Holding
1,523
New
87
Increased
195
Reduced
484
Closed
113
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$232M |
| 2 |
Take-Two Interactive
TTWO
|
+$188M |
| 3 |
AZPN
Aspen Technology Inc
AZPN
|
+$103M |
| 4 |
Markel Group
MKL
|
+$51.1M |
| 5 |
Veralto
VLTO
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$1.08B |
| 2 |
Entegris
ENTG
|
+$151M |
| 3 |
American Tower
AMT
|
+$74.3M |
| 4 |
Apple
AAPL
|
+$39.5M |
| 5 |
Microsoft
MSFT
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 45.75% |
| 2 | Technology | 17.98% |
| 3 | Consumer Discretionary | 8.5% |
| 4 | Healthcare | 8.28% |
| 5 | Communication Services | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Roivant Sciences
ROIV
$25.2B
| $120K | ﹤0.01% |
11,400
+400
| +4% | +$4.31K |
|
727
Western New England Bancorp
WNEB
$288M
| $119K | ﹤0.01% |
15,518
| – | – |
|
728
NXP Semiconductors
NXPI
$67.3B
| $117K | ﹤0.01% |
471
| – | – |
|
729
Apple Hospitality REIT
APLE
$4B
| $117K | ﹤0.01% |
7,125
| – | – |
|
|
DO
730
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $116K | ﹤0.01% |
8,500
| – | – |
|
731
McGrath RentCorp
MGRC
$2.93B
| $115K | ﹤0.01% |
+930
| New | +$112K |
|
732
Sun Communities
SUI
$15B
| $114K | ﹤0.01% |
890
-56
| -6% | -$7.27K |
|
733
USCB Financial Holdings
USCB
$410M
| $114K | ﹤0.01% |
10,000
| – | – |
|
734
Coursera
COUR
$1.59B
| $114K | ﹤0.01% |
8,125
| – | – |
|
735
Primerica
PRI
$9.87B
| $114K | ﹤0.01% |
450
| – | – |
|
736
iShares Core US Aggregate Bond ETF
AGG
$138B
| $114K | ﹤0.01% |
+1,162
| New | +$114K |
|
737
Aldeyra Therapeutics
ALDX
$94.7M
| $114K | ﹤0.01% |
34,745
| – | – |
|
738
Progressive
PGR
$125B
| $113K | ﹤0.01% |
545
-200
| -27% | -$37.1K |
|
739
Sonoco
SON
$5.77B
| $112K | ﹤0.01% |
1,940
+890
| +85% | +$50.8K |
|
740
SAB Biotherapeutics
SABS
$271M
| $112K | ﹤0.01% |
24,577
-3,201
| -12% | -$17.6K |
|
741
Opko Health
OPK
$929M
| $109K | ﹤0.01% |
90,525
+50,000
| +123% | +$50K |
|
742
iShares Russell 3000 ETF
IWV
$19.5B
| $108K | ﹤0.01% |
360
| – | – |
|
743
iShares MSCI EAFE Value ETF
EFV
$28.3B
| $108K | ﹤0.01% |
1,983
| – | – |
|
744
Cerus
CERS
$609M
| $108K | ﹤0.01% |
57,000
| – | – |
|
745
Ducommun
DCO
$2.69B
| $108K | ﹤0.01% |
2,100
-1,250
| -37% | -$62.3K |
|
746
Hercules Capital
HTGC
$2.97B
| $107K | ﹤0.01% |
5,825
| – | – |
|
747
Royalty Pharma
RPRX
$26.2B
| $106K | ﹤0.01% |
3,500
-5
| -0.1% | -$147 |
|
748
Toronto Dominion Bank
TD
$199B
| $106K | ﹤0.01% |
1,752
-90
| -5% | -$5.44K |
|
749
Dell
DELL
$270B
| $106K | ﹤0.01% |
926
| – | – |
|
750
Ventas
VTR
$48.8B
| $106K | ﹤0.01% |
2,425
| – | – |
|
Similar funds
SAM
First Manhattan's Q1 2024 Portfolio in Review
As of Q1 2024, First Manhattan held 1,523 positions worth $30.9B, up 7.1% from $28.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
First Manhattan withdrew a net $960M in Q1 2024, closing 113 positions and reducing 484 holdings. Its most notable exit was Arrowhead Research, an estimated $22.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 46% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, First Manhattan opened a new position in Travelers Companies worth $10.2M.
- First Manhattan's largest Q1 2024 buy was Travelers Companies: 44,199 shares worth $10.2M.
- First Manhattan added most to Applied Materials in Q1 2024, an estimated $232M increase.
- First Manhattan's biggest Q1 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $1.08B.
- First Manhattan fully exited Arrowhead Research in Q1 2024, selling an estimated $22.8M.
- First Manhattan's ten largest holdings make up 60% of its $30.9B portfolio in Q1 2024.
- First Manhattan opened 87 new positions and closed 113 in Q1 2024.
- First Manhattan's portfolio value rose 7.1% quarter-over-quarter to $30.9B.
Based on First Manhattan's 13F filing for Q1 2024, filed 15 May 2024.